The present study showed that circulating BNP significantly increased in T2DM patients with osteoporosis, and circulating BNP was independently and positively correlated with the prevalence of diabetic osteoporosis, thereby suggesting that circulating BNP may be used as a useful biomarker of risk of osteoporosis in T2DM patients. This evidence concerns the gene NPPB and osteoporosis.